Stemson Therapeutics Establishes Headquarters on the Sanford Burnham Prebys Medical Discovery Institute Campus in La Jolla, CA

Stemson Therapeutics has established its headquarters in La Jolla, CA on the Sanford Burnham Prebys Medical Discovery Institute (SBP) campus, centered in one of the premier biomedical research hubs in the United States.  Stemson’s unique cell therapy solution to treat alopecia is based on Induced Pluripotent Stem Cell (iPSC) technology originally developed at SBP by Stemson co-founder, Dr. Alexey Terskikh.  By incubating within the institute, Stemson will have access to world class research and development facilities to support the final product development in preparation for clinical trials.

“The Stemson team is thrilled to establish our company on the SBP campus,” says co-founder and CEO, Geoff Hamilton.  “The institute is a fountainhead for biomedical innovation and discoveries.  As a spin-out of SBP, we are fortunate to leverage their capabilities and their people.”

Stemson Therapeutics is a pre-clinical stage cell therapy company with a mission to cure hair loss.  Our proprietary iPSC-derived folliculogenic cells hold the unique potential to generate de novo hair follicles providing the first-ever new supply of follicles to those suffering from hair loss.